Giotto Biotech’s protein expertise is committed to support you with your coronavirus (COVID-19) research
Starting from the beginning of the worldwide COVID-19 pandemic, Giotto Biotech’s scientists team is working to develop a wide range of high-quality recombinant proteins related to SARS-CoV-2 and is committed to support you with your coronavirus (COVID-19) research.
All our proteins are expressed in E. coli and purified using only aqueous buffer (no organic solvents are used, thus leaving the folding and chirality of the biological products unaffected). The quality of our products is guaranteed by SDS-pages, mass spectrometry and NMR spectra.
Products are for research use only.
If you don’t see what are you looking for, please ask!
We would be happy to work with you to meet your needs.
Available recombinant proteins related to SARS-CoV-2